Arasali, Baby Boy .
HRN: 21-35-20 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2022
AMOXICILLIN 250MG/5ML, 60ML SUSPENSION (BOT)
08/16/2022
08/22/2022
ORAL
2ml
TID
AGE
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes